BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP
Lftd Partners Inc. LIFD
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$36.9M
▼ 1.1% vs FY2024
EPS · FY25
$-1.68
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-99.2%
Net margin · FY25
-67.3%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 36.9M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
The company lost 67 cents on every revenue dollar this year.
Per share
USD -1.68
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-99.2%
Return on equity, FY2025
ROE
Operating margin2.5%
Net margin-67.3%
Return on assets-74.3%
Each USD of equity lost 99 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 0.00
Share of profit-0.0%
Consecutive raises—
Growth
+47.2% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−13.7%
+47.2%
+14.5%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.01B
Shares outstanding, FY2025
Change, 5 years+20.1%
Change, 10 years—
The share count grew 20% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 19.3M
total assets, end of FY2025
Total assetsUSD 19.3M
EquityUSD 12.6M
CashUSD 1.8M
DepositsUSD 1.0M
Current ratio3.04×
Equity funds 66% of total assets.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.1
0.1
0.0
0.0
0.0
·
·
·
·
·
·
0.0
0.0
0.0
Operating income $B
0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
·
·
·
·
·
−0.0
−0.0
−0.0
EBITDA $B
0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
·
·
·
·
·
·
−0.0
−0.0
−0.0
Income tax $B
0.0
−0.0
0.0
−0.0
0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
·
0.0
0.0
Net income $B
−0.0
−0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
EPS, diluted $
−1.68
−0.13
0.13
0.45
0.43
−0.29
−0.48
−0.09
−0.03
−0.08
−0.52
−2.34
1.61
−0.86
−1.86
−0.09
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
0
−1
−0
·
·
·
·
·
·
·
·
·
ROE %
−99.2
−4.9
5.9
23.2
23.6
−11.0
−41.5
·
·
·
−189.2
−410.0
·
·
·
·
Shares out B
0.01
0.01
0.01
0.01
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
57 of 58
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 1 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed